Changes in Cognitive Functioning in Euthymic Bipolar Patients Treated With Lurasidone Versus Treatment as Usual; A Randomized, Open-Label Study
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2017
Price : $35 *
At a glance
- Drugs Lurasidone (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- 03 Dec 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 27 May 2015 Planned End Date changed from 1 Feb 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.
- 27 May 2015 Planned primary completion date changed from 1 Feb 2015 to 1 Mar 2016, as reported by ClinicalTrials.gov.